Acquiring Company
Crescita Therapeutics
Acquired Company
Laboratoire Provence-Canada
Description
Crescita Therapeutics Inc. has acquired select assets from Laboratoire Provence-Canada Inc., enhancing its manufacturing capabilities. The transaction includes key assets such as accounts receivable, inventories, and intellectual property related to the Bacti Control® brand for $775. Additionally, Crescita has secured a five-year exclusive supply agreement to manufacture products for one of LPC’s largest customers. This acquisition is aimed at bolstering recurring revenues and improving operational efficiency.
Quick answer
Crescita Therapeutics is acquiring Laboratoire Provence-Canada, announced November 6, 2025. Crescita Therapeutics is based in Laval, Quebec, Canada.
- How much did Crescita Therapeutics pay for Laboratoire Provence-Canada?
- The deal value was not disclosed.
- What does Crescita Therapeutics do?
- Crescita Therapeutics Inc. is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities.
- Where are Crescita Therapeutics and Laboratoire Provence-Canada based?
- Crescita Therapeutics is based in Laval, Quebec, Canada. Laboratoire Provence-Canada is based in Quebec, Canada.
Source: Fundz verified event record.
Other recent acquisitions in Cosmetics and Fashion
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Wildberries & Russ acquires Rive Gauche cosmetics chain (December 15, 2025)
- Honasa Consumer acquires Reginald Men for grooming market (December 11, 2025)
- Centric Brands acquires Vingino to enhance growth (December 2, 2025)
- SiteOne acquires French Broad Stone Yards (November 25, 2025)
- ClearPoint Neuro acquires IRRAS for $5 million, $5M (November 20, 2025)
- GCPL acquires Muuchstac for Rs 450 crore (November 14, 2025)
Who to call at Crescita Therapeutics, and when
When Crescita Therapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Crescita Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Crescita Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Crescita Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Crescita Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Laboratoire Provence-Canada?
Laboratoire Provence-Canada was acquired by Crescita Therapeutics, based in Laval. The deal was reported on November 6, 2025. Crescita Therapeutics Inc. is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities. Crescita Therapeutics is privately held and operates in Manufacturing.
When did Crescita Therapeutics acquire Laboratoire Provence-Canada?
Crescita Therapeutics's acquisition of Laboratoire Provence-Canada was reported on November 6, 2025. Crescita Therapeutics Inc. has acquired select assets from Laboratoire Provence-Canada Inc., enhancing its manufacturing capabilities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Laboratoire Provence-Canada do?
Laboratoire Provence-Canada Inc. is a company specializing in the development and manufacturing of cosmetics and natural health products. With a focus on quality and innovation, LPC caters to various brands and retail partners. It is privately held, operating in Manufacturing, and is based in Quebec.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.